Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 579
Aptamer sequence: CACGGCATGGTGGGCGTCGTG
Target unique ID: 6249
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_546 AMP4 Molecule Ampicillin 9.4 nM 20 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM KCl, 5 mM MgCl2 22222912
Structure information of aptamer
Aptamer Sequence: CACGGCATGGTGGGCGTCGTG
The optimal secondary structure in dot-bracket notation: ((((((.........))))))
The centroid secondary structure in dot-bracket notation: ((((((.........))))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_546 Description AMP4
Aptamer chemistry DNA Length 21 nt
GC content 71.4% Molecular weight 6,519.19 Da
Molarity of 1 μg/μl solution 153.39 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Aptasensor
Sequence CACGGCATGGTGGGCGTCGTG
Applications Aptasensor for ampicillin
Target information
Type Detail Type Detail
PubChem ID 6249 Molecular name Ampicillin
Molecular formula C16H19N3O4S Molecular weight 349.4
IUPAC name (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid InChIKey AVKUERGKIZMTKX-NJBDSQKTSA-N
LogP 0.318 Topological polar surface area 112.73
Hydrogen bond acceptor 5 Hydrogen bond donor 3

Synonym(s):
69-53-4; Ampicillin; Aminobenzylpenicillin; Ampicillin acid; Amcill; Polycillin; Principen; Omnipen; Ampicilline; Penbritin; Pentrexyl; Synpenin; Tokiocillin; Totacillin; Novo-ampicillin; D-Ampicillin; Ampicillin Anhydrous; D-(-)-Ampicillin; Adobacillin; Amblosin; Ampichel; Ampicilina; Ampicillinum; Ampifarm; Ampipenin; Ampiscel; Amplacilina; Amplipenyl; Amplisom; Amplital; Bonapicillin; Britacil; Campicillin; Copharcilin; Delcillin; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Lifeampil; Norobrittin; Orbicilina; Penbristol; Penbrock; Penicline; Pentrexl; Princillin; Racenacillin; Rosampline; Roscillin; Semicillin; Servicillin; Sumipanto; Texcillin; Totalciclina; Trifacilina; Ultrabion; Ultrabron; Viccillin; Acillin; Amfipen; Ampicil; Ampikel; Ampimed; Ampisyn; Ampivax; Ampivet; Amplin; Binotal; Morepen; Nuvapen; Penimic; Pensyn; Pentrex; Ponecil; Tolomol; Totapen; Vampen; Cimex; Supen; anhydrous ampicillin; Ampicillin anhydrate; Pfizerpen A; Amipenix S; Ampi-bol; SK-Ampicillin; Amfipen V; Pen Ampil; QIDamp; Ampi-Tab; D-Cillin; Olin Kid; Ro-Ampen; Ampi-Co; Austrapen; Pen A; Ampicillina [DCIT]; Bayer 5427; D-(-)-alpha-Aminobenzylpenicillin; ABPC; Ampicilina [INN-Spanish]; Ampicilline [INN-French]; Ampicillinum [INN-Latin]; Ampicin; D-(-)-alpha-Aminopenicillin; Deripen; Wypicil; Alpen; Ampicillin A; Polycillin-N; Totacillin-N; Penbritin-S; AY-6108; Omnipen-N; BRL 1341; Penbritin syrup; Semicillin R; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; P-50; KS-R1; Penbritin paediatric; NSC-528986; AB-PC; BRL-1341; 6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; Guicitrine; Ampen; NSC 528986; AB-PC Sol; Ampicillin, anhydrous; UNII-7C782967RD; C16H19N3O4S; CHEBI:28971; MFCD00005175; Alpha-Aminobenzylpenicillin; 6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; MLS000028405; (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Ampicillina; HI 63; Ukapen; Pfizerpen-A; WY-5103; AMPI; 7C782967RD; P 50; SQ 17382; Penicillin, (aminophenylmethyl)-; SMR000058352; Ampicillin Base; DSSTox_CID_2602; AY 6108; DSSTox_RID_76654; DSSTox_GSID_22602; (2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; Polyflex (Veterinary); ampicillanyl; Ampicillin [USAN:BAN:INN:JAN]; CAS-69-53-4; (2S,5R,6R)-6-[(R)-2-Amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID; Omnipen (TN); Totacillin (sodium); BA 7305; HSDB 3009; AMPICILLIN/AMPICILLIN TRIHYDRATE; Ampicillin (USP/INN); EINECS 200-709-7; vidopen; Vidocillin; Marcillin; Pentritin; NSC528986; D-(-)-.alpha.-Aminobenzylpenicillin; Ampicillin,(S); NCGC00018160-02; (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-; Ampicillin [USAN:USP:INN:BAN:JAN]; Ampicillin (anhydrous); Spectrum_000050; 1h8s; AY 6108; D-a-Aminobenzylpenicillin; Opera_ID_1630; Prestwick0_000114; Prestwick1_000114; Prestwick2_000114; Prestwick3_000114; Spectrum2_000769; Spectrum3_000301; Spectrum4_000149; Spectrum5_000814; CHEMBL174; Epitope ID:115008; Epitope ID:116057; EC 200-709-7; SCHEMBL3526; BSPBio_000128; BSPBio_001862; KBioGR_000598; KBioSS_000430; Anhydrous ampicillin (JP17); MLS001074168; BIDD:GT0184; DivK1c_000466; SPBio_000818; SPBio_002067; Ampicillin, analytical standard; D-(-)-a-Aminobenzylpenicillin; BPBio1_000142; DTXSID4022602; CHEBI:53713; GTPL10896; KBio1_000466; KBio2_000430; KBio2_002998; KBio2_005566; KBio3_001362; NINDS_000466; HMS2090I11; HMS2233H23; Ampicillin acid; Principen; Amcill; HY-B0522; ZINC3830218; Tox21_113049; Tox21_301416; BDBM50350465; AKOS015888156; Tox21_113049_1; AC-8805; DB00415; VA10275; WY 5103; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; IDI1_000466; SMP1_000211; NCGC00023282-05; NCGC00023282-06; NCGC00023282-21; NCGC00178944-03; NCGC00248937-01; NCGC00255127-01; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, D-(-)-; BA166034; SBI-0051283.P003; 6-(a-Aminophenylacetamido)penicillanic acid; C06574; D00204; A936108; AMPICILLIN ANHYDROUS, PHARMACEUTICAL GRADE; Q244150; 6-D(-)-alpha-Aminophenylacetamido-penicillanic acid; BRD-K68432770-001-08-0; Ampicillin, anhydrous, 96.0-100.5% (anhydrous basis); Ampicillin, United States Pharmacopeia (USP) Reference Standard; Anhydrous ampicillin, British Pharmacopoeia (BP) Reference Standard; Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard; (2S,5R,6R)-6-(((R,E)-2-Amino-1-hydroxy-2-phenylethylidene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2R)-aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S,5R,6R)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-, trihydrate,(2S,5R,6R)-; 6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI; AMPICILLIN; D(-)-ALPHA-AMINOBENZYLPENICILLIN; 6-[D(-)-ALPHA-AMINOPHENYLLACETAMIDO]PENICILLANIC ACID

Activity data

No relevant experimental diagram

Interaction ID 579
Target type Molecule
Target unique ID 6249
Activity 9.4 nM
Binding Conditions/Buffer

20 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM KCl, 5 mM MgCl2

Assay

N/A

PubMed ID 22222912
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_630 DNA GACCAGGGCAAACGGTAGGGAGTGGTC 59.26%
Apta_75 DNA CACTGGTAGGTTGGTGTGGTTGGGGCCAGTG 58.06%
Apta_64 DNA ACCGTGTGGAGGGTGTT 57.14%
Apta_209 DNA AAGGCTTTAGGTCTG 57.14%
Apta_211 DNA GGTTGGTGTGGTTGG 57.14%
Apta_1098 DNA ATGGCCAGGGGGGAGGGG 57.14%
Apta_679 DNA CAGGTGGCAGATCGGGTGTGGGTGGCCTGG 56.67%
Apta_10 DNA GGGGGGGGTGGCTGGGCGGGGTGGG 56.00%
Apta_12 DNA TGAGGGGGTGGGTGGGACGGGTTGG 56.00%
Apta_20 DNA AGAGGGGGGGGTGGGGGTGGCCTGC 56.00%
Apta_24 DNA TGTGGGGATGGATGGGCCGGGCTGC 56.00%
Apta_25 DNA TGTGGGGGTGGTTGGGCGGGGCTGC 56.00%
Apta_329 DNA GGCGTACGGTAGGCGGGGTCAACTG 56.00%
Apta_700 DNA GCAGGGGCGTTCGGGGGGTACCGCTGC 55.56%
Apta_701 DNA GTACTGGCGTTCGGGGGGTACCGCTGC 55.56%
Apta_702 DNA TACCCGGCGTTCGGGGGGTACCGCTGC 55.56%
Apta_350 DNA GGTGGTGGTGGTTGTGGTGGTGGTGG 53.85%
Apta_541 DNA CACGTGTTGTCTCTCTGTGTCTCGTG 53.85%
Apta_1019 DNA ATCCCTGCAGTTTGGTAGGGTGCAGG 53.85%
Apta_419 DNA ATCAGGGCTAAAGAGTGCAGAGTTACTTAG 53.33%